Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
Merrimack Pharmaceuticals (MACK) - Total assets
Total assets on the balance sheet as of December 2023 : $19.18 M
According to Merrimack Pharmaceuticals's latest financial reports the company's total assets are $19.18 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Merrimack Pharmaceuticals - Total assets on balance sheet (from 2010 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $19.18 M | -3.27% |
| 2022-12-31 | $19.83 M | 34.49% |
| 2021-12-31 | $14.74 M | -12.08% |
| 2020-12-31 | $16.77 M | -16.46% |
| 2019-12-31 | $20.08 M | -77.32% |
| 2018-12-31 | $88.54 M | -24.53% |
| 2017-12-31 | $0.11 B | 43.99% |
| 2016-12-31 | $81.48 M | -65.31% |
| 2015-12-31 | $0.23 B | 48.18% |
| 2014-12-31 | $0.15 B | -17.62% |
| 2013-12-31 | $0.19 B | 29.16% |
| 2012-12-31 | $0.14 B | 74.65% |
| 2011-12-31 | $85.29 M | 48.15% |
| 2010-12-31 | $57.57 M | -29.92% |
| 2009-12-31 | $82.15 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $139.81 B | 728,563.75% | 🇫🇷 France |
 Geron GERN | $0.39 B | 1,953.76% | 🇺🇸 USA |
 Clovis Oncology CLVS | $0.34 B | 1,707.25% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $0.10 B | 427.58% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $49.13 M | 156.06% | 🇺🇸 USA |